Insufficient scRNA-seq data for expression of GPSM1 at single-cell level.
Insufficient scRNA-seq data for expression of GPSM1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 4417.61 | 2632 / 2642 | 100% | 67.01 | 703 / 705 |
prostate | 100% | 3824.98 | 245 / 245 | 99% | 19.24 | 498 / 502 |
skin | 99% | 2543.86 | 1794 / 1809 | 98% | 32.27 | 463 / 472 |
thymus | 99% | 1584.78 | 645 / 653 | 96% | 12.81 | 578 / 605 |
pancreas | 99% | 2487.08 | 326 / 328 | 94% | 12.44 | 167 / 178 |
ovary | 100% | 4462.72 | 180 / 180 | 92% | 16.09 | 395 / 430 |
breast | 96% | 1640.56 | 440 / 459 | 91% | 12.44 | 1014 / 1118 |
adrenal gland | 100% | 2135.62 | 257 / 258 | 86% | 14.54 | 198 / 230 |
lung | 100% | 4461.91 | 577 / 578 | 83% | 10.73 | 958 / 1155 |
uterus | 100% | 3594.55 | 170 / 170 | 74% | 14.32 | 339 / 459 |
kidney | 99% | 1891.06 | 88 / 89 | 73% | 7.31 | 654 / 901 |
bladder | 100% | 1866.62 | 21 / 21 | 63% | 7.59 | 319 / 504 |
esophagus | 78% | 1360.90 | 1130 / 1445 | 74% | 9.67 | 136 / 183 |
stomach | 100% | 1628.10 | 359 / 359 | 46% | 4.85 | 132 / 286 |
intestine | 89% | 1647.53 | 856 / 966 | 40% | 4.05 | 211 / 527 |
eye | 0% | 0 | 0 / 0 | 100% | 50.75 | 80 / 80 |
ureter | 0% | 0 | 0 / 0 | 100% | 17.07 | 1 / 1 |
spleen | 99% | 2200.15 | 239 / 241 | 0% | 0 | 0 / 0 |
heart | 99% | 4895.13 | 853 / 861 | 0% | 0 | 0 / 0 |
adipose | 96% | 1445.35 | 1161 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 96% | 1734.05 | 1281 / 1335 | 0% | 0 | 0 / 0 |
liver | 9% | 80.39 | 21 / 226 | 60% | 7.86 | 244 / 406 |
tonsil | 0% | 0 | 0 / 0 | 53% | 4.87 | 24 / 45 |
lymph node | 0% | 0 | 0 / 0 | 21% | 1.29 | 6 / 29 |
muscle | 2% | 21.40 | 20 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 1% | 5.23 | 6 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_1905098 | Biological process | negative regulation of guanyl-nucleotide exchange factor activity |
GO_0000132 | Biological process | establishment of mitotic spindle orientation |
GO_0007399 | Biological process | nervous system development |
GO_0034260 | Biological process | negative regulation of GTPase activity |
GO_0016239 | Biological process | positive regulation of macroautophagy |
GO_0030154 | Biological process | cell differentiation |
GO_0000139 | Cellular component | Golgi membrane |
GO_0032991 | Cellular component | protein-containing complex |
GO_0005829 | Cellular component | cytosol |
GO_0005938 | Cellular component | cell cortex |
GO_0005886 | Cellular component | plasma membrane |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0005092 | Molecular function | GDP-dissociation inhibitor activity |
GO_0001965 | Molecular function | G-protein alpha-subunit binding |
GO_0005515 | Molecular function | protein binding |
Gene name | GPSM1 |
Protein name | G protein signaling modulator 1 G-protein-signaling modulator 1 (Activator of G-protein signaling 3) |
Synonyms | AGS3 |
Description | FUNCTION: Guanine nucleotide dissociation inhibitor (GDI) which functions as a receptor-independent activator of heterotrimeric G-protein signaling. Keeps G(i/o) alpha subunit in its GDP-bound form thus uncoupling heterotrimeric G-proteins signaling from G protein-coupled receptors. Controls spindle orientation and asymmetric cell fate of cerebral cortical progenitors. May also be involved in macroautophagy in intestinal cells. May play a role in drug addiction. . |
Accessions | ENST00000616132.4 ENST00000429455.5 [Q86YR5-2] ENST00000291775.3 [Q86YR5-2] A0A087WVF5 A0A0A0MRC4 ENST00000440944.6 A0A0A0MSK4 Q86YR5 ENST00000392944.5 [Q86YR5-2] ENST00000354753.7 |